Clinical Research, Pharma & Healthcare FinancingVerastem Oncology to Present AVMAPKI FAKZYNJA Combo TherapyBusiness WireMarch 18, 2026March 19, 2026 by Business WireMarch 18, 2026March 19, 2026016 Plenary oral presentation features long-term follow-up data from the Phase 2 RAMP 201 recurrent low-grade serous ovarian cancer clinical trial Verastem Oncology (Nasdaq: VSTM), a...